Bank of New York Mellon’s Astrana Health ASTH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $10.9M | Buy |
234,896
+13,054
| +6% | +$470K | ﹤0.01% | 1980 |
|
|
2026
Q1 | $5.44M | Sell |
221,842
-7,822
| -3% | -$185K | ﹤0.01% | 2261 |
|
|
2025
Q4 | $5.7M | Sell |
229,664
-15,607
| -6% | -$414K | ﹤0.01% | 2245 |
|
|
2025
Q3 | $6.95M | Sell |
245,271
-6,649
| -3% | -$180K | ﹤0.01% | 2132 |
|
|
2025
Q2 | $6.27M | Sell |
251,920
-1,332
| -0.5% | -$37.5K | ﹤0.01% | 2145 |
|
|
2025
Q1 | $7.85M | Sell |
253,252
-13,624
| -5% | -$454K | ﹤0.01% | 1985 |
|
|
2024
Q4 | $8.41M | Sell |
266,876
-1,826
| -0.7% | -$86.7K | ﹤0.01% | 2013 |
|
|
2024
Q3 | $15.6M | Sell |
268,702
-47,604
| -15% | -$2.34M | ﹤0.01% | 1710 |
|
|
2024
Q2 | $12.8M | Buy |
316,306
+6,766
| +2% | +$268K | ﹤0.01% | 1831 |
|
|
2024
Q1 | $13M | Sell |
309,540
-13,065
| -4% | -$510K | ﹤0.01% | 1829 |
|
|
2023
Q4 | $12.4M | Sell |
322,605
-7,154
| -2% | -$238K | ﹤0.01% | 1857 |
|
|
2023
Q3 | $10.2M | Sell |
329,759
-3,943
| -1% | -$136K | ﹤0.01% | 1932 |
|
|
2023
Q2 | $10.5M | Sell |
333,702
-26,468
| -7% | -$908K | ﹤0.01% | 1926 |
|
|
2023
Q1 | $13.1M | Sell |
360,170
-10,951
| -3% | -$383K | ﹤0.01% | 1783 |
|
|
2022
Q4 | $11M | Buy |
371,121
+7,423
| +2% | +$239K | ﹤0.01% | 1891 |
|
|
2022
Q3 | $14.2M | Buy |
363,698
+14,974
| +4% | +$685K | ﹤0.01% | 1688 |
|
|
2022
Q2 | $13.5M | Sell |
348,724
-6,835
| -2% | -$260K | ﹤0.01% | 1768 |
|
|
2022
Q1 | $17.2M | Sell |
355,559
-8,873
| -2% | -$458K | ﹤0.01% | 1763 |
|
|
2021
Q4 | $26.8M | Buy |
364,432
+20,292
| +6% | +$1.67M | ﹤0.01% | 1541 |
|
|
2021
Q3 | $31.3M | Buy |
344,140
+148,582
| +76% | +$12.6M | 0.01% | 1452 |
|
|
2021
Q2 | $12.3M | Buy |
195,558
+86,651
| +80% | +$3.2M | ﹤0.01% | 2021 |
|
|
2021
Q1 | $2.95M | Buy |
108,907
+1,299
| +1% | +$31.2K | ﹤0.01% | 2698 |
|
|
2020
Q4 | $1.97M | Buy |
107,608
+24,896
| +30% | +$448K | ﹤0.01% | 2854 |
|
|
2020
Q3 | $1.48M | Buy |
82,712
+15,591
| +23% | +$269K | ﹤0.01% | 2866 |
|
|
2020
Q2 | $1.11M | Buy |
67,121
+7,343
| +12% | +$116K | ﹤0.01% | 3046 |
|
|
2020
Q1 | $772K | Sell |
59,778
-1,551
| -3% | -$25.3K | ﹤0.01% | 3146 |
|
|
2019
Q4 | $1.13M | Sell |
61,329
-38,402
| -39% | -$637K | ﹤0.01% | 3179 |
|
|
2019
Q3 | $1.76M | Buy |
99,731
+38,384
| +63% | +$657K | ﹤0.01% | 2818 |
|
|
2019
Q2 | $1.02M | Buy |
61,347
+1,205
| +2% | +$21.9K | ﹤0.01% | 3193 |
|
|
2019
Q1 | $1.1M | Buy |
60,142
+280
| +0.5% | +$5.37K | ﹤0.01% | 3107 |
|
|
2018
Q4 | $1.19M | Buy |
59,862
+23,217
| +63% | +$434K | ﹤0.01% | 3013 |
|
|
2018
Q3 | $809K | Sell |
36,645
-24,805
| -40% | -$522K | ﹤0.01% | 3388 |
|
|
2018
Q2 | $1.59M | Buy |
+61,450
| New | +$1.05M | ﹤0.01% | 2989 |
|
Other funds holding ASTH
SW
IWS
WP
LTAS
Bank of New York Mellon's ASTH Position: Q2 2026 in Review
Bank of New York Mellon increased its Astrana Health (ASTH) stake by 5.9% in Q2 2026, buying an estimated $470K and bringing the position to 234,896 shares worth $10.9M. The position accounts for ﹤0.01% of the portfolio, ranked #1980.
Bank of New York Mellon first reported a position in ASTH in Q2 2018 and has held it in 33 quarters since. The position peaked at $31.3M in Q3 2021. 80 funds tracked by Wall St. Rank hold ASTH as of Q2 2026.
- Bank of New York Mellon held 234,896 shares of Astrana Health worth $10.9M as of Q2 2026.
- Bank of New York Mellon bought 13,054 Astrana Health shares in Q2 2026, an estimated $470K.
- Astrana Health made up ﹤0.01% of Bank of New York Mellon's portfolio in Q2 2026, its #1980 holding.
- Bank of New York Mellon first reported a position in Astrana Health in Q2 2018 and has held it in 33 quarters since.
- Bank of New York Mellon's Astrana Health position peaked at $31.3M in Q3 2021.
- 80 funds tracked by Wall St. Rank held Astrana Health as of Q2 2026.
Based on Bank of New York Mellon's 13F filing for Q2 2026, filed 6 Aug 2026.